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Abstract - Homocysteine is a significant but modifiable risk factor for vascular diseases. As gastrointestinal smooth mus-
culature is similar to blood vessel muscles, we investigated how elevated homocysteine levels affect nitric oxide-mediated 
neurotransmission in the gut. There is accumulated evidence that a dysfunction of NO neurons in the myenteric plexus 
may cause various diseases in the gastrointestinal tract such as achalasia, diabetic gastroparesis and infantile hypertrophic 
pyloric stenosis. In the present study, we aimed to assess the effects of homocysteine on NO-mediated responses in vitro, 
and to examine the effects of DL-homocysteine thiolactone on the spontaneous motility of rat duodenum and nitrergic 
neurotransmission. DL-homocysteine thiolactone concentration of 10 μmol/L leads to the immediate increase in tone, 
amplitude and frequency of spontaneous movements in isolated rat duodenum. L-NAME (30 μmol/L) leads to an increase 
in basal tone, amplitude and frequency of spontaneous contractions. The relaxations induced by EFS were significantly 
reduced in duodenal segments incubated in DL-homocysteine thiolactone compared with the control group. EFS-induced 
relaxations were inhibited by L-NAME in both experimental and control groups. These results suggest that a high level of 
homocysteine causes an important impairment of non-adrenergic non-cholinergic innervation of the rat duodenum.
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INTRODUCTION
Homocysteine  (Hcy)  is  a  sulfur-containing  amino 
acid that is not used for the synthesis of proteins (de 
Bree et al., 2002). Hcy is formed when cells metabo-
lize the essential amino acid methionine. An elevated 
plasma homocysteine level is a risk factor for vascu-
lar disease, including coronary, cerebrovascular or 
peripheral arterial disease, and is a good predictor 
of atherothrombotic events (Eichinger et al., 1998; 
Hankey and Eikelboom, 1999; Lentz, 1998). Mecha-
nisms responsible for the association between hyper-
homocysteinemia  and  vascular  disease  are  poorly 
understood (Lentz et al., 1996). While several patho-
logical processes may be involved, homocysteine can 
cause significant endothelial impairment and com-
promise vascular NO bioactivity (Fu et al., 2002). 
Gastrointestinal smooth musculature is similar 
to blood vessel muscles. We investigated how elevat-
ed homocysteine levels affect NO-mediated neuro-
transmission in the gut.1324 MARIJA STOJANOVIĆ ET AL.
The mammalian gut wall contains a distinct class 
of  intrinsic  inhibitory  motoneurons,  the  so-called 
non-adrenergic  non-cholinergic  (NANC)  neurons 
(Glaskow et al., 1998). These neurons mediate func-
tional relaxations of the gut. Nitrergic neurotrans-
mitters, acting via the release of NO, are thought to 
be the responsible transmitters of this NANC inhibi-
tory motor innervation. NO serves as the primary 
enteric inhibitory neurotransmitter in GI muscles, 
and nitrergic neurons regulate gut tone, phasic con-
tractile amplitude, frequency, and inhibitory reflexes 
(Sanders and Ward, 1992). NO also regulates the ac-
commodation reflex of the fundus and the peristaltic 
reflex of the intestine (Takahashi, 2003). At least a 
portion of the mechanical effect of NO are a conse-
quence of the hyperpolarization of membrane poten-
tial that results in reduced smooth muscle excitabil-
ity. There is accumulated evidence that a dysfunction 
in NO neurons in the myenteric plexus may cause 
various  diseases  in  the  gastrointestinal  tract  such 
as achalasia, diabetic gastroparesis, infantile hyper-
trophic pyloric stenosis and Hirschsprung’s disease. 
Reduced  NO  release  and/or  nNOS  expression  are 
suspicious  in  a  subset  of  patients  with  functional 
dyspepsia. Although the etiology of intestinal pseu-
do-obstruction remains unknown, it is conceivable 
that extrinsic denervation may upregulate nNOS ex-
pression, resulting in enhanced muscular relaxation 
and disturbed peristalsis (Takahashi, 2003).
Hyperhomocysteinemia  (HHcy)  has  been  im-
plicated in inflammation and remodeling in the in-
testinal vasculature and it is known to aggravate the 
pathogenesis of inflammatory bowel disease (IBD). 
There are results indicating that HHcy decreases in-
testinal motility due to matrix metalo-proteinase-9 
(MMP-9)-induced intestinal remodeling leading to 
constipation (Givvimani et al., 2012). Oral diet for 12 
weeks was able to reduce constipation and laxative 
use and improve gut health. It is assumed that this 
will lead to improved plasma levels of homocysteine 
(Sturtzel et al., 2010). Increased homocysteine levels 
in the colonic mucosa and plasma of patients with 
inflammatory bowel disease may play a role in the 
pathogenesis of Crohn’s disease and ulcerative colitis. 
Patients who have inflammatory bowel disease are 
also at higher risk for hyperhomocysteinemia, which 
increases their susceptibility to thrombotic events. 
Patients with inflammatory bowel disease (IBD) fre-
quently experience thromboembolic complications 
(Papa  et  al.,  2001)  which  represent  an  important 
cause of morbidity and mortality. Elevated homo-
cysteine levels increased the risk of Crohn’s disease 
and ulcerative colitis. Vitamin B12 and folate supple-
mentation in patients with IBD significantly reduced 
homocysteine  concentrations  (Fernández-Miranda 
et al., 2005). 
The aim of this study was to investigate the ef-
fects of DL-homocysteine thiolactone on the sponta-
neous motility of isolated rat duodenum, and on the 
effects of NANC relaxation of this part of the small 
intestine. 
MATERIALS AND METHODS
Experiments were carried out on male Wistar albi-
no rats, weighing from 250-300 g. After the animals 
were killed by cervical dislocation under urethane 
anesthesia, a duodenal segment about 2 cm in length 
was quickly removed just distal to the pylorus and 
placed in a 50-ml thermostatically controlled (37ºC) 
organ bath containing Tyrode’s solution in the fol-
lowing  composition  (mM):  NaCl  136.9,  KCl  2.7, 
CaCl2 1.0, NaHCO3 11.9, NaH2PO4 0.4 and glucose 
5.6. The pH of the solution was 7.4 during bubbling 
with 5% CO2 in O2. The preparations were placed 
under a resting tension of 1 g. Contractile tone and 
its variations were recorded by means of an isomet-
ric transducer connected to a Sensor Medics Dyno-
graph recorder R511A recorder. To produce adren-
ergic and cholinergic blockade, all experiments were 
performed in the presence of atropine (3 x 10-6 M) 
plus guanethidine (3 x 10-6 M). 
To determine the effect of NO on spontaneous 
contractions of longitudinal duodenal muscle strips, 
segments were exposed to L-NAME (NOS inhibitor) 
and L-arginine (the substrate for NOS). Electrical 
field  stimulation  was  delivered  by  platinum  elec-
trodes placed parallel to the strip, connected to a Ugo 
Basile stimulator. Square wave pulses (0.5 ms pulse RAT DUODENAL MOTILITY IN VITRO 1325
duration, maximal voltage, 50 V) were delivered for 
10 s frequencies of 1 to 5 Hz. 
Tissue  responses  (resting  tone,  amplitude  of 
contraction) were measured as changes in isometric 
tension of the duodenum. The responses were then 
calculated and expressed in milligrams (mg). Fre-
quency of contractions was calculated as the number 
of contractions per minute. 
Before testing, segments were allowed to equil-
ibrate in Tyrode’s solution for 60 min. During this 
time,  the  nutrient  solution  was  changed  every  20 
min. 
The drugs used were DL-homocysteine thiolac-
tone,  L-NG-nitroarginine  methyl  ester  (L-NAME), 
L-arginine, guanethidine, atropine, and all were ob-
tained  from  Sigma  Chemical  Company  (St  Louis, 
MO, USA).
Statistical analysis
All values are expressed as the mean ± SEM. Statisti-
cal evaluation was done with the software GraphPad 
Prism Instat 5.0 (GraphPad Software; CA, USA). The 
data were analyzed by means of two-way analysis of 
variance (ANOVA). Statistical evaluation of the data 
was done following Student’s t-test. For all compari-
sons, p<0.05 was considered significant.
RESULTS
Spontaneous activity of longitudinal muscle strips of 
isolated rat duodenum
After  a  one-hour  adaptation  period,  duodenal 
muscle strips showed spontaneous motility. Ampli-
tude moved from 118.10 to 124.60 mg, with a mean 
value of 120.30±0.93 mg (n=10). Frequency of spon-
taneous movements was 9.17-10.33 per minute, aver-
age 9.81±0.17. The tonus of spontaneous contractions 
was 98.33-106.70, with a mean value 102.90±1.17 mg 
(Fig. 1). 
Effects of DL-homocysteine thiolactone on the tone, 
amplitude and frequency of spontaneous contractions 
of isolated rat duodenum
DL-homocysteine thiolactone in a concentration of 
10 µmоl/L increased the resting tone, amplitude and 
frequency,  and  this  effect  takes  place  and  reaches 
maximum after 30 min incubation period (Figs. 2, 
3, 4). The difference between control values and val-
ues in the presence of DL-homocysteine thiolactone 
in the 30-min period was assessed every 5 min. The 
mean values were tested by Student t test. The differ-
ence was statistically significant (*p<0.05). 
 
Fig. 1. Spontaneous activity of longitudinal muscle strips of iso-
lated rat duodenum during a 6 min period.
  Fig. 2. The effects of DL-homocysteine thiolactone on the tone 
of spontaneous contractions of isolated rat duodenum (*statisti-
cally different from the control group, p<0.05).1326 MARIJA STOJANOVIĆ ET AL.
Effects of L-NAME and L-arginine on the tone,  
amplitude and frequency of spontaneous contractions 
of isolated rat duodenum
L-NAME increases the resting tone, amplitude and 
frequency of spontaneous contractions of longitudi-
nal muscle layers of isolated rat duodenum compared 
with the control group (Figs. 5, 6, 7). This effect ap-
pears after application and lasts for 5 min. When the 
compound was applied 5 min before the addition of 
L-NAME incubated in 10µmol/L L-arginine, the ef-
 
Fig. 3. The effects of DL-homocysteine thiolacton on the am-
plitude of spontaneous contractions of isolated rat duodenum 
(*statistically different from the control group, p<0.05).
 
Fig. 4. The effects of DL-homocysteine thiolactone on the fre-
quency of spontaneous contractions of isolated rat duodenum 
(*statistically different from the control group, p<0.05).
 
Fig. 5. The effects of L-NAME on the tone of spontaneous con-
tractions of isolated rat duodenum (*statistically different from 
the control group, p<0.05).
  Fig. 6. The effects of L-NAME on the amplitude of spontaneous 
contractions  of  isolated  rat  duodenum  (*statistically  different 
from the control group, p<0.05).
 
Fig. 7. The effects of L-NAME on the frequency of spontaneous 
contractions  of  isolated  rat  duodenum  (*statistically  different 
from the control group, p<0.05).RAT DUODENAL MOTILITY IN VITRO 1327
fects of L-NAME were significantly reduced, but not 
completely blocked. 
Effects of L-NAME on the tone, amplitude and  
frequency of spontaneous contractions of isolated rat 
duodenum in the presence of DL-homocysteine  
thiolactone
The samples were incubated for 30 min in the 
presence of DL-homocysteine thiolactone, and 
then 30 µmоl/L L-NAME was added. There was 
an increase in the resting tone, amplitude and 
frequency  of  spontaneous  contractions  of  the 
longitudinal muscle layers of isolated rat duode-
num compared with the control group (Figs. 5, 
6, 7). The mean values were tested by Student’s 
t test. The difference was statistically significant 
(*p<0.05).
Effects of electrical field stimulation on spontaneous 
activity of isolated duodenal segments
Isolated longitudinal duodenal segments were stim-
ulated for 10 s. At the beginning of stimulation, there 
was a relaxation that lasted for 1 s. After stimulation 
“off” response was made, the contractions lasted 1.5 
s in all experiments. 
L-NAME impact on the effects of electrical field  
stimulation of isolated duodenal segments in the  
presence of DL-homocysteine thiolactone
Duodenal preparations were initially exposed to a 
concentration of DL-homocysteine thiolactone of 10 
μmol/L. A current increase of the amplitude of spon-
taneous contractions was observed. Immediately af-
ter the addition of homocysteine in the organ bath, 
electrical field stimulation (50 V, 1Hz, 0.5 ms, 10 s) 
was carried out. After 5 min, 30 μmol/L of L-NAME 
was administrated and the effects of L-NAME were 
recorded at the end of the incubation period (Fig. 
8). 
DISCUSSION
Our research was conducted to investigate the effects 
of DL-homocysteine thiolactone on NANC neuro-
transmission in isolated rat duodenum. Increasing 
epidemiological  and  experimental  studies  indicate 
that even a mild elevation of plasma homocysteine 
(Hcy) concentration (plasma Hcy > 16 μmol/L) is 
an  independent  risk  factor  for  occlusive  diseases, 
atherosclerosis, diabetes mellitus, hypertension and 
end-stage  renal  failure  (Stampfer  and  Malinow, 
1995). However, to our knowledge, its effect in hu-
man  gastrointestinal  (GI)  smooth  muscle  has  not 
been studied in detail. 
In this paper we wanted to examine the effects 
of DL-homocysteine thiolactone on duodenal motil-
ity, which has proved to have a prokinetic effect. Our 
results show that DL-homocysteine thiolactone in-
creases the resting tone, amplitude and the frequency 
of spontaneous contractions. Our results are consist-
ent with those of Park et al., which suggest that sul-
fur-containing  amino  acids  like  DL-homocysteine 
potentiate  the  depolarization  of  murine  proximal 
colon cells. These effects include increasing the am-
plitude and frequency of spontaneous contractions 
of murine colonic stripes (Park et al., 2005). 
Choe et al. (2012) investigated the effects of me-
thionine on the contractile activity of human colon 
smooth muscle in vitro. Methionine is a sulfur-con-
Fig. 8. L-NAME impact on the effects of electrical field stimula-
tion of isolated duodenal segments in the presence of DL-ho-
mocysteine thiolactone (*statistically different from the control 
group, p<0.05).
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taining amino acid that is transformed into homo-
cysteine during biometabolism. Their results indicate 
that methionine increases the amplitude of colonic 
muscle strips. 
It has been widely recognized that stimulation of 
a certain class of nerves within the wall of the gut 
elicits  relaxation  (Allescher  et  al.,  1993;  Mourelle 
et al., 1993; Szilvassy et al., 1996). These nerves are 
non-adrenergic and non-cholinergic and have been 
commonly referred to as NANC nerves. These neu-
rons are extremely important because they mediate 
the majority of inhibitory responses in the GI tract 
and regulate many important physiological reflexes, 
such as relaxation of the lower esophageal sphincter 
after swallowing, receptive relaxation of the proxi-
mal stomach during eating, and reducing inhibition 
in response to distension (Takahashi, 2003). Many 
reports have identified a role of NO in NANC neu-
romuscular transmission in many tissues, such as the 
ileocolonic junction and duodenum of dog, the gas-
tric fundus in rat and the low esophageal sphincter in 
opossum (Kasakov et al., 1995; Bult et al., 1990; Toda 
et al., 1991; Boeckxstaens et al., 1991; Tottrup et al., 
1991). The most potent inhibitor of NO production 
is L-NAME (Rees et al., 1990). L-NAME has been 
used by many investigators to determine the role of 
endogenous nitric oxide in various physiological and 
pathophysiological conditions. 
In  our  experiments,  L-NAME  showed  an  in-
crease in the resting tone, amplitude and frequency 
of the contractions of isolated duodenal segments. It 
has been shown that L-arginine reversed the action 
of L-NAME. In the presence of L-NAME, treatment 
with 10 μmol/L DL-homocysteine thiolactone caused 
a significant increase in resting tone, amplitude and 
the frequency of contractions. These results suggest 
that the mechanisms of Hcy action on duodenal seg-
ment contractions are based on the modulation of 
nitrergic neurotransmission in the gut. 
Transmural electrical stimulation of all segments 
induced relaxation that was maximal at frequency 
of 10 Hz. Relaxation occurred at the beginning of 
stimulation  “on”  response.  A  rebound  contraction 
was observed after cessation of the stimulus – “off” 
response. 
Karasu et al. (2008) showed that EFS-induced 
relaxations are mediated mainly by NO in rat duode-
num. These findings suggest that the impairment of 
nitrergic innervation of rat duodenum may contrib-
ute to abnormalities of intestinal motility.
In our study, L-NAME, a nitric oxide synthase 
inhibitor,  inhibited  low  frequency  electrical  stim-
ulation-induced relaxation. This indicated that en-
dogenous NO is involved in NANC relaxation of rat 
duodenum. These data confirm the evidence of the 
participation of the L-arginine-NO pathway in neu-
rally induced isolated rat duodenum. Importantly, 
NANC  relaxations  induced  by  low  frequencies  of 
EFS were significantly changed in duodenal prepara-
tions obtained from duodenal segments treated with 
high homocysteine concentration levels. These find-
ings suggest that homocysteine causes an important 
impairment of NANC innervation of the rat duode-
num. Contrary to our results, Karasu et al. (2008) 
suggest  that  experimental  hyperhomocysteinemia, 
induced by methionine diet 12 weeks prior to study, 
does not cause a significant change in NANC-medi-
ated responses of rat duodenum. 
DL-homocysteine thiolactone enhances the con-
tractile activity of isolated rat duodenum. DL-homo-
cysteine thiolactone also reverses the effect of nitrergic 
stimulation in the duodenal muscle strip. We assume 
that a compound mimicking DL-homocysteine thi-
olactone  may  provide  prokinetic  functions  in  the 
human gastrointestinal tract. Motility disorders that 
seem to benefit from prokinetics are postoperative 
ileus, acute colonic pseudo-obstruction, chronic in-
testinal pseudo-obstruction, idiopathic constipation, 
Hirschsprung’s disease and constipation. 
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